VEGF/PD-1 Bispecifics.
Wonderful discussion by Dr. Thomas Grinda on the prospects.
Several Phase III studies planned.
@oncbrothers.bsky.social @sabcs.bsky.social @oncoalert.bsky.social
VEGF/PD-1 Bispecifics.
Wonderful discussion by Dr. Thomas Grinda on the prospects.
Several Phase III studies planned.
@oncbrothers.bsky.social @sabcs.bsky.social @oncoalert.bsky.social